InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Browse the detailed record of transactions filed by Willwerth Christina, Directeur de la Stratégie. Director active across 1 companies, notably Flexion Therapeutics Inc. In total, 4 disclosures have been logged. Total volume traded: €43k. The latest transaction was disclosed on 19 November 2021 (Disposition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
€1m141,241 shares@ €7.476998.0% of flow
Common Stock
SEC:0001209191-21-065707·
€1m141,241 shares@ €7.476949.0% of flow
Common Stock
SEC:0001209191-21-065707:0·
€21,5753,945 shares@ €5.4692.0% of flow
Common Stock
SEC:0001209191-21-047506·
€21,5753,945 shares@ €5.4691.0% of flow
Common Stock
SEC:0001209191-21-047506:0·
4 of 4 declarations
About Willwerth Christina
Christina Willwerth is the Chief Strategy Officer at Flexion Therapeutics Inc. In this role, she is responsible for developing and implementing the company's growth strategies. Willwerth plays a key role in analyzing market trends and identifying expansion opportunities. Her strategic vision helps guide Flexion Therapeutics toward new heights.
